MLTX Stock Analysis: Buy, Sell, or Hold?
MLTX - MoonLake Immunotherapeutics Class A Ordinary Shares
$15.76
-0.11 (-0.69%)
▼
5d:
-4.31%
30d:
-18.6%
90d:
-14.67%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 11, 2026
0d
Get Alerted When MLTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: MLTX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: MLTX shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: MLTX is currently trading at $15.76, which is considered oversold relative to its 30-day fair value range of $16.78 to $19.48.
Technical Outlook: Technically, MLTX is showing sideways momentum. The price is currently testing key support at $15.54. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $28.54 (+81.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MLTX is showing sideways momentum. The price is currently testing key support at $15.54. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $28.54 (+81.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$16.78 -
$19.48
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Protect Your Profits
Holding MLTX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 81.1% below Wall St target ($28.54)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$16.78 -
$19.48
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$15.55
Resistance Level
$17.77
Current Trend
Sideways
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.72
Wall Street Target
$28.54
(+81.1%)
Share & Embed Analysis
Last updated: August 23, 2026 1:59 AM ET
Data refreshes hourly during market hours. Next update: 2:59 AM
Data refreshes hourly during market hours. Next update: 2:59 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MLTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Da Silva Jorge Santos
SELL
51873 shares
2026-04-13
Da Silva Jorge Santos
SELL
98127 shares
2026-04-10
Bvf Partners L P/Il
SELL
3750000 shares
2026-03-31
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 58 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 54 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 40 SELL |
|
EYPT
EyePoint, Inc |
STRONG BUY
13 analysts |
$41 | 44 HOLD |
Advanced MLTX Option Strategies
Professional options setups generated by AI based on today's MLTX price and gamma walls.
